E lastic fi bers are required for the elasticity and integrity of various organs. We and others previously showed that fi bulin-5 (also called developing arteries and neural crest EGF-like [DANCE] or embryonic vascular EGF-like repeat-containing protein [EVEC]) is indispensable for elastogenesis by studying fi bulin-5-defi cient mice, which recapitulate human aging phenotypes caused by disorganized elastic fi bers (Nakamura, T., P.R. However, the molecular mechanism by which fi blin-5 contributes to elastogenesis remains unknown. We report that fi bulin-5 protein potently induces elastic fi ber assembly and maturation by organizing tro poelastin and cross-linking enzymes onto microfi brils. Deposition of fi bulin-5 on microfi brils promotes coacervation and alignment of tropoelastins on microfi brils, and also facilitates cross-linking of tropoelastin by tethering lysyl oxidase-like 1, 2, and 4 enzymes. Notably, recombinant fi bulin-5 protein induced elastogenesis even in serum-free conditions, although elastogenesis in cell culture has been believed to be serum-dependent. Moreover, the amount of full-length fi bulin-5 diminishes with age, while truncated fi bulin-5, which cannot promote elastogenesis, increases. These data suggest that fi bulin-5 could be a novel therapeutic target for elastic fi ber regeneration.
Introduction
Elastic fi bers play a crucial role in the structural integrity and function of various organs (Rosenbloom et al., 1993) . The loss of elasticity leads to many age-related phenotypes, such as wrinkled skin, emphysema, and arteriosclerosis (Pasquali-Ronchetti and Baccarani- Contri, 1997; Bailey, 2001) . Therapeutic intervention for these age-related changes has not been realized because the mechanisms of the development and maintenance of elastic fi bers remain unclear. Elastic fi bers comprise two distinct components: an amorphous core of cross-linked elastin surrounded by a peripheral mantle of microfi brils. In the process of elastic fi ber assembly, elastin precursors (tropoelastin) are deposited on microfi brils, aligned in an orderly way, and cross-linked by lysyl oxidase (LOX) enzymes to form mature elastin, which confers the elastic properties to elastic fi bers (Rosenbloom et al., 1993) . However, the molecular mechanism of this multistep process remains largely unknown (Kielty et al., 2002) .
Tropoelastin, which is a major constituent of the elastic fi ber, can interact with other tropoelastin molecules and selfaggregate at physiological temperatures. Thus, tropoelastins undergo a phase transition, which is termed coacervation, from soluble monomers to insoluble aggregates (Urry, 1988) . In elastic fi ber assembly, coacervation is considered to play a critical role through concentrating and aligning tropoelastin before crosslinking. However, coacervation of tropoelastins alone is not suffi cient to explain the assembly process and the variable forms of elastic fi bers in different tissues. For fi brillar deposition of tropoelastin, microfi brils, which are mainly composed of fi brillin-1 and -2, are assumed to act as scaffolds, and to direct the morphogenesis of elastic fi bers. In fact, mice defi cient in both fi brillin-1 and -2 were recently reported to exhibit impaired Fibulin-5/DANCE has an elastogenic organizer activity that is abrogated by proteolytic cleavage in vivo (Carta et al., 2006) , indicating that fi brillins are required for the initial assembly of elastic fi bers. The fi nal cross-linking step is initiated by oxidative deamination of tropoelastins, which is catalyzed by LOXs (Kagan and Li, 2003) . LOXs are copper-containing monoamine oxidases secreted by fi brogenic cells, such as fi broblasts and smooth muscle cells. Five LOX family members have been identifi ed so far: LOX, LOX-like 1 (LOXL1), 2, 3, and 4 (Molnar et al., 2003) . LOX-defi cient mice were reported to die perinatally because of insuffi cient cross-linking of elastin and collagens (Maki et al., 2002; Hornstra et al., 2003) . LOXL1-defi cient mice were reported to live to adulthood, but to have degenerated elastic fi bers, suggesting that LOXL1 is also important for the development and/or maintenance of elastic fi bers (Liu et al., 2004 ). Yet, little is known about how LOXs are recruited to catalyze tropoelastins on microfi brils.
Thus, the elastic fi ber assembly involves recruitment and organized deposition of various molecules, and seems to be tightly regulated and fi nely tuned to achieve the appropriate elastic properties in each organ. However, whether there are any specifi c molecules organizing the assembly of elastic fi ber components remains unknown. Recently, we and others showed that the elastic fi ber assembly process requires fi bulin-5 (also known as developing arteries and neural crest EGF-like [DANCE] or embryonic vascular EGF-like repeat-containing protein [EVEC] ) by thoroughly investigating fi bulin-5-defi cient mice Figure 1 . Fibulin-5 potently induces elastic fi ber development and promotes tropoelastin coacervation. (A-C) Human skin fi broblasts were cultured in 10% fetal bovine serum-containing medium (A), in serum-free medium (B), and in serum-free medium with 8 μg/ml of purifi ed recombinant FLAG-tagged fi bulin-5 protein (C). Cultures were stained with anti-FLAG (top) or anti-human elastin (middle) antibody. The bottom images were produced by superimposition of the top and middle images, together with DAPI nuclear staining. (D-G) Human skin fi broblasts were cultured in serum-free medium with 0, 2, 4, or 8 μg/ml of purifi ed FLAGtagged recombinant fi bulin-5 protein, to examine the dose-dependency of fi bulin-5 elastogenic activity. Cultures were stained as in A-C. Bars, 50 μm. (Nakamura et al., 2002; Yanagisawa et al., 2002) . These mice recapitulate human aging phenotypes, such as loose skin, emphysematous lungs, and stiff arteries because of disorganized elastic fibers. Fibulin-5 has an Arg-Gly-Asp motif at the N-terminal domain and interacts with cell surface integrins, such as αvβ5, αvβ3, and α9β1 (Nakamura et al., 1999 (Nakamura et al., , 2002 . Fibulin-5 also has tandem arrays of calcium-binding EGF-like domains and a characteristic C-terminal fi bulin domain, and these structures enable it to interact with several elastic fi ber components, such as elastin (Yanagisawa et al., 2002; Freeman et al., 2005) , EMILIN (Zanetti et al., 2004) , and LOXL1 (Liu et al., 2004) . Thus, fi bulin-5 is a good candidate for an organizer of elastogenesis that scaffolds elastic fi ber components in the vicinity of cell surfaces. However, the specifi c role of fi bulin-5 in elastogenesis, whether fibulin-5 can promote elastogenesis, and whether there is a correlation of aging-associated alterations of fi bulin-5 with aging phenotypes, remains unknown.
We report that recombinant fi bulin-5 protein potently induces elastic fi ber assembly, even in serum-free cell culture, without changing the expression of elastic fi ber components, suggesting that fi bulin-5 serves as an organizer molecule for elastogenesis. Fibulin-5 deposits on microfibrils, promotes aggregation of tropoelastin molecules through coacervation, and also interacts with LOXL1, 2, and 4, which are enzymes that cross-link elastin. We propose a model in which fi bulin-5 tethers LOXL enzymes to microfi brils, thus facilitating aggregation and cross-linking of elastin on microfi brils. Intriguingly, a much lower level of full-length fi bulin-5, and a higher level of a truncated form of fi bulin-5 were detected in aged mouse loose skin than in young mouse skin because of proteolytic cleavage of the N-terminal domain. The cleavage of fi bulin-5 abrogates fi bulin-5-microfi bril interaction, leading to loss of the elastic fi ber-organizing activity of fi bulin-5.
Results

Fibulin-5 promotes assembly of elastic fi ber components
To elucidate the molecular role of fi bulin-5 in elastogenesis, we established an in vitro system to evaluate elastic fi ber assembly, using human skin fi broblast cultures. In the presence of fetal bovine serum, skin fi broblasts developed an abundant meshwork of elastic fi bers, which were stained with antielastin antibody ( Fig. 1 A) , as previously reported (Mecham, 1987) . In the absence of serum, they did not develop elastic fi bers (Fig. 1 B) . Investigation of elastogenic factors has been hampered by the Figure 2 . Quantitative PCR analysis in skin fi broblasts after addition of recombinant full-length fi bulin-5 or truncated form of fi bulin-5. Total RNA from skin fi broblasts was extracted 2 d after addition of recombinant proteins in the serum-free culture media. cDNA was synthesized and was subjected to quantitative real-time PCR for the expression of elastin, LOXL1, LOX, fi brillin-1, -2, and glyceraldehyde-3-phosphate dehydrogenase (Gapdh) transcripts. A graphic presentation of results obtained by real-time PCR is shown. Levels of Gapdh transcript were used to normalize cDNA levels. The relative amount of PCR product amplifi ed from control fi broblasts was set at 100. Data are presented as triplicates, and the means ± the SD are shown. The primers used are shown in Table S1 , available at http://www.jcb .org/cgi/content/full/jcb.200611026/DC1. serum dependency of elastogenesis in cell culture, as serum contains various proteins of known and unknown functions (Mecham, 1987) . Surprisingly, we found that skin fi broblasts developed an abundant meshwork of elastic fi bers, even in serum-free media, when they were cultured with purifi ed recombinant fi bulin-5 protein (Fig. 1 C) . Staining with anti-FLAG antibody revealed that added fi bulin-5 protein colocalized with elastin. Recombinant fi bulin-5 protein induced elastic fi ber assembly in a dose-dependent manner in serum-free medium (Fig. 1, D-G) . We scarcely detected endogenous fi bulin-5 in serum-free culture, whereas we detected abundant deposition of fi bulin-5 in serum-containing culture (Fig. S1 , available at http://www.jcb.org/cgi/content/full/jcb.200611026/DC1). Addition of fi bulin-5 protein did not affect the mRNA expression of elastic fi ber components (e.g., elastin and fi brillins; Fig. 2 ), indicating that a suffi cient amount of elastic fi ber components was produced even in serum-free culture, but that they could not be organized into elastic fi bers without the addition of fi bulin-5 protein. These data suggest that fi bulin-5 is not a signaling molecule that changes gene expression, but an organizer molecule that promotes assembly of elastic fi ber components.
Fibulin-5 promotes coacervation of tropoelastin
Tropoelastin, which is the precursor of elastin, can interact with other tropoelastin molecules and self-aggregate at physiological temperatures through a phase transition termed coacervation (Urry, 1988; Vrhovski et al., 1997) . Coacervation is considered to be an important step before cross-linking of tropoelastin molecules for elastic fi ber assembly (Urry, 1988; Vrhovski et al., 1997) .
Because fi bulin-5 can directly interact with tropoelastin (Yanagisawa et al., 2002) , we examined whether fi bulin-5 can affect the coacervation of tropoelastin. Purifi ed recombinant tropoelastin protein coacervated at 35-40°C, causing the solution to become turbid (Fig. 3) . In the presence of recombinant fi bulin-5 protein, tropoelastin started to coacervate at lower temperatures (Fig. 3) , suggesting that fibulin-5 promotes coacervation of tropoelastin.
The switching of fi bulin-5 subtypes occurs with age, whereas elastic matrices are deteriorated Fibulin-5-defi cient mice exhibit aging-related characteristics, including loose skin, emphysema, and stiff arteries, because of disorganized elastic fi ber development (Nakamura et al., 2002; Yanagisawa et al., 2002) . Because tissue elastic properties are gradually reduced with aging (Pasquali-Ronchetti and Baccarani- Contri, 1997; Bailey, 2001) , we examined the age-related changes of elastic matrices by observing skin tissues of young and old mice with transmission electron microscopy. As shown in Fig. 4 A, elastic fi bers were disorganized and fragmented in old mice, whereas they were organized into thick fi brous structures in young mice (Fig. 4 A, middle and top). The deteriorated elastic fi bers in old mice closely resemble the disorganized and fragmented elastic fi bers found even in young fi bulin-5-defi cient mice (Fig. 4 A, middle and bottom). Next, we investigated whether the expression of fi bulin-5 is altered during aging, as we inferred from the data in the previous sections that suggested fi bulin-5 is not only necessary for elastogenesis but also able to promote elastic fi ber organization. Using skin tissues of young and old mice, we performed Western blotting with anti-fi bulin-5 antibody (BSYN2473). As shown in Fig. 4 B, we detected two specifi c bands in wild-type mice, while we did not detect any band in fi bulin-5-defi cient mice. Notably, the intensity of the upper bands was considerably decreased in the old mice compared with the young mice ( Fig. 4 B, compare lanes 1-3 with lanes 4-6). On the other hand, the intensity of the bottom bands increased remarkably in the old mice (Fig. 4 B, compare lanes 1-3 with lanes 4-6). From these results, we hypothesized that the switching of fi bulin-5 subtypes may affect the elastogenic activity of fi bulin-5 and be correlated with the deterioration of elastic matrices during aging.
Fibulin-5 is partially cleaved in vitro
Because only one major transcript of fi bulin-5 was detected by Northern blot analysis (Nakamura et al., 1999) and no mRNA or EST that would code for a protein ‫01ف‬ kD smaller or larger than the major form of fi bulin-5 protein was found in public databases, the two subtypes of fi bulin-5 protein we observed were not thought to be splice variants, but were rather considered to be indicative of posttranslational modifi cation. To investigate this modifi cation, we transfected an expression vector containing fi bulin-5 cDNA with a signal peptide and a FLAG tag at the N terminus into 293T cells. The culture medium of these cells was collected and subjected to Western blotting. As shown in Fig On the other hand, we detected only one 55-kD band with anti-FLAG antibody (Fig. 4 C, right). These results suggest that fi bulin-5 may be cleaved at a more N-terminal position than the recognition site of antifi bulin-5 antibody (Fig. 4 D) . We deduced that the lower 45-kD band is the cleaved form of fi bulin-5, while the upper 55-kD band is the full-length fi bulin-5. The cleaved N-terminal fragment of fi bulin-5 appears to be easily degraded because we did not detect a 10-kD band corresponding to this fragment with anti-FLAG antibody.
Fibulin-5 is specifi cally cleaved after arginine at position 77 by a serine protease
To identify the cleavage site of fi bulin-5, we stably transfected the C-terminal-histidine-tagged expression vector encoding fi bulin-5 cDNA into 293T cells. We purifi ed recombinant fi bulin-5 protein from the conditioned medium of these cells with immobilized metal affi nity chromatography, and examined the purifi ed protein by SDS-PAGE. As expected, we detected two bands stained with Coomassie blue, and the lower 45-kD band was assumed to be the cleaved form of fi bulin-5. We sequenced the N-terminal end of the lower band using Edman degradation (Fig. 5 A, arrow) , and determined that fi bulin-5 is cleaved after the arginine at position 77 (Fig. 5 B, top and middle) . The upper 55-kD band was also confi rmed by protein sequencing to be the full-length fi bulin-5, as the N-terminal sequence coincided with the predicted cleavage site after the signal peptide. As many proteases are arginine-specifi c, we examined whether the arginine at position 77 is necessary for the cleavage of fi bulin-5. We constructed an expression vector encoding R77A mutant fi bulin-5, which was mutated from arginine to alanine at position 77 ( Fig. 5 B, bottom) , and transfected this R77A mutant fi bulin-5 vector into 293T cells, followed by Western blotting. As shown in Fig. 5 C, we detected only the upper 55-kD band, whereas the lower 45-kD band disappeared (lane 2), indicating that the R77A mutant fi bulin-5 is resistant to cleavage. These results indicate that fi bulin-5 is specifi cally cleaved after the arginine at position 77 (Fig. 5 C, compare lanes 1 and 2) , although we cannot rule out the possibility that fi bulin-5 might not be cleaved in vivo at the same site as in vitro cell culture. Next, we examined the nature of the protease that cleaves fi bulin-5. We transiently transfected the expression vector encoding C-terminal FLAGtagged fi bulin-5 cDNA into 293T cells, and subsequently added different types of protease inhibitors to the culture medium, which was subjected to Western blotting. Whereas a cysteine protease inhibitor, E64, did not inhibit the cleavage of fi bulin-5 at all, a serine protease inhibitor, aprotinin, completely inhibited the cleavage (Fig. 5 C, compare lanes 3 and 4) . These results indicate that fi bulin-5 is cleaved by a serine protease in vitro. We have not yet succeeded in identifying the serine protease that cleaves fi bulin-5.
Full-length fi bulin-5 can deposit on microfi brils, whereas the truncated form of fi bulin-5 cannot
To assess the functional consequence of fi bulin-5 cleavage, we studied the interaction of fi bulin-5 and microfi brils. Microfi brils, Figure 4 . The N-terminal domain cleavage of fi bulin-5 is found in aged mouse skin, as well as in cell cultures. (A) Fine structure of elastic fi bers in skin tissues observed by transmission electromicroscopy. Elastin was stained with tannic acid, and therefore appears as black amorphous material. The fi ne fi bers surrounding elastin are microfi brils. Bar, 0.4 μm. (B) Skin tissues were harvested from wild-type or fi bulin-5-defi cient young (3-mo-old) and old (22-mo-old) mice. Proteins were extracted from skin tissues with 8 M urea and dialyzed against PBS. 10 μg each of these extracts were resolved by SDS-PAGE, and analyzed by Western blotting with anti-fi bulin-5 antibody (BSYN2473). Two specifi c bands of 45 and 55 kD were detected in wild-type mice with anti-fi bulin-5 antibody (lanes 1-3) . The 55-kD band markedly decreased with age, whereas the 45-kD band markedly increased with age (lanes 4-6). (C) 293T cells were transiently transfected with an expression vector encoding fi bulin-5 cDNA with a signal peptide and a FLAG tag at the N terminus. Conditioned medium was subjected to SDS-PAGE, followed by Western blotting analysis with either antifi bulin-5 or anti-FLAG antibody. Two bands of 55 and 45 kD were detected with anti-fi bulin-5 antibody, whereas only a 55-kD band was detected with anti-FLAG antibody. (D) Anti-fi bulin-5 antibody (BSYN2473) was raised against a peptide corresponding to amino acids 76-98 (red mark). These fi ndings suggest that fi bulin-5 is cleaved at a more N-terminal position than the recognition site of anti-fi bulin-5 antibody.
which are mainly composed of fi brillin-1 and -2, are considered to serve as scaffolds for tropoelastin deposition and subsequent elastic fi ber assembly. Fibroblast cell cultures developed fi ne meshworks of fi brillin-1 microfi brils, even under serum-free conditions, at days 4-7 of culture (Fig. 5, D-F) ; this is much earlier than elastin deposition, which requires >10 d of culture in serum-containing medium. When we added recombinant fi bulin-5 protein to the culture, fi bulin-5 colocalized with fi brillin-1 microfi brils. However, when we added recombinant truncated fi bulin-5 protein to the culture, the added truncated fi bulin-5 did not deposit on fi brillin-1 microfi brils. This was not because the truncated form of fi bulin-5 is susceptible to degradation, as Western blot analysis of the culture medium showed that truncated form of fi bulin-5 was as stable as the full-length fi bulin-5 in the medium (Fig. 5 G) . These data indicate that full-length fi bulin-5 can deposit on microfi brils, whereas the truncated form of fi bulin-5 cannot.
The cleavage of fi bulin-5 causes inactivation of the elastogenic activity of fi bulin-5
Next, we investigated the consequences of the functional change caused by the cleavage of fi bulin-5 in elastic fi ber assembly, using the in vitro elastogenesis assay shown in Fig. 1 A with recombinant fi bulin-5 and the truncated form of fi bulin-5 proteins. Whereas wild-type fi bulin-5 potently induced elastic fi ber development, the truncated form of fi bulin-5 did not induce elastic fi ber development at all (Fig. 6, B and C) . Therefore, we concluded that the cleavage of fi bulin-5 causes inactivation of the elastogenic activity of fi bulin-5.
Cross-linking of elastin is promoted by prealigned fi bulin-5 on microfi brils
The assembly of functional elastic fi bers requires not only fi brillar deposition and coacervation of tropoelastin, but also cross-linking of tropoelastin. The aforementioned data suggest that deposition of fi bulin-5 onto microfi brils accelerates fi brillar tropoelastin deposition, but it was not clear if the tropoelastin molecules are cross-linked to form mature functional elastic fi bers. To examine this, we added β-aminopropionitrile (BAPN), an irreversible inhibitor of LOXs (Tang et al., 1983) , to serumfree skin fi broblast culture containing recombinant fi bulin-5 protein. It is known that LOXs, which are cross-linking enzymes for elastin monomers, are necessary for elastic fi ber maturation (Hornstra et al., 2003; Liu et al., 2004; Maki et al., 2002) . As shown in Fig. 6 D, elastins showed only a dotlike deposition when elastin cross-linking was largely inhibited by BAPN, whereas fi brillar deposition of fi bulin-5 on microfi brils was not affected by BAPN. This punctuate distribution of elastin is displayed by tropoelastin coacervates before cross-linking (Clarke et al., 2006) . These data indicate that elastic fi bers organized by the addition of fi bulin-5 protein are cross-linked and mature fi bers, and that not only deposition and aggregation but also Figure 5 . Fibulin-5 is cleaved after the arginine at position 77 by serine protease and loses the microfi brilassociating activity. (A) 293T cells were stably transfected with an expression vector encoding C-terminal-FLAGand 6× histidine-tagged fi bulin-5 cDNA. Recombinant fi bulin-5 protein was purifi ed by chelating chromatography from the culture media of these cells, subjected to SDS-PAGE, and stained with Coomassie blue. The lower band (arrow) was subjected to N-terminal sequencing. (B) The N-terminal sequencing of the lower band identifi ed the specifi c cleavage site of fi bulin-5 at the arginine at position 77. (C) 293T cells were transiently transfected with the expression vector encoding C-terminal-FLAG-and 6× histidine-tagged fi bulin-5 or R77A mutant fi bulin-5, which had a mutation from arginine to alanine at position 77. Transfected cells were cultured for 2 d with or without a cysteine protease inhibitor, E64, or a serine protease inhibitor, aprotinine, added to the culture media. Culture media were then harvested, concentrated by chelating chromatography, and subjected to Western blotting with anti-FLAG antibody. (D-G) Human skin fi broblasts were cultured for 4 d in serum-free medium in the presence of recombinant fi bulin-5 (D) or recombinant cleaved fi bulin-5 (E) proteins at a concentration of 4 μg/ml in the medium, or without recombinant protein (F). The cells were then double-stained with anti-fi brillin-1 polyclonal antibody (top) and with anti-FLAG monoclonal antibody (middle). Bottom images were produced by superimposition of the top and middle images, together with DAPI nuclear staining. Bars, 60 μm. At the same time, the conditioned medium was immunoblotted with anti-FLAG antibody to confi rm that neither fi bulin-5 nor cleaved fi bulin-5 was degraded during the culture period (G).
cross-linking of elastin is promoted by prealigned fibulin-5 on microfi brils.
The N-terminal domain-truncated fi bulin-5 loses the elastogenic activity, but does not interfere with elastic fi ber assembly
We next examined whether cleaved fi bulin-5 is merely inactive or works against elastogenesis in a dominant-negative manner. For this purpose, we quantifi ed the amount of elastic fi bers induced by full-length fi bulin-5 with or without cleaved fi bulin-5. We metabolically labeled newly synthesized elastin with [ 3 H]valine (Keeley, 1976) , and measured the incorporation of [ 3 H]valine in the NaOH-insoluble fraction of these cells, which refl ects the amount of mature elastic fi bers (Hinek et al., 2000) . As shown in Fig. 6 E, we detected substantial, dose-dependent incorporation of [ 3 H]valine upon adding recombinant fi bulin-5 to the medium (Fig. 6 E, compare lanes 1-4) . On the other hand, cleaved fi bulin-5 showed neither an additive nor a dominantnegative effect on fi bulin-5-induced elastic fi ber development (Fig. 6 E, compare lanes 1-7) . These results indicate that fi bulin-5 simply loses its elastogenic activity as a result of cleavage of the N-terminal domain.
LOXL1, 2, and 4 proteins mainly interact with the C-terminal domain of fi bulin-5
To develop mature elastic fi bers, tropoelastin molecules need to be highly cross-linked by LOXs. Five LOX family members have been identifi ed so far, LOX, LOXL1, 2, 3, and 4 (Molnar et al., 2003) . Mice lacking LOX and mice lacking LOXL1 were recently reported to show profound fragmentation of elastic fi bers (Maki et al., 2002; Hornstra et al., 2003; Liu et al., 2004) . Moreover, LOXL1 has been reported to interact with fi bulin-5 (Liu et al., 2004) . To investigate whether fi bulin-5 interacts with other LOX family members, we performed in vitro binding assays using Myc-tagged LOX and LOXLs, and the set of FLAG-tagged fi bulin-5 deletion mutant constructs shown in Fig. 7 A. As shown in Fig. 7 B, we detected the specifi c interaction of LOXL1, 2, and 4 proteins with fi bulin-5 protein (top, lanes 1, 7, and 13). The interaction of fi bulin-5 and these LOXL proteins was eliminated or considerably diminished by the C-terminal deletion of fi bulin-5 (Fig. 7 B, top, lanes 5, 11, and 17) . These results indicate that LOXL1, 2, and 4 proteins mainly interact with the C-terminal domain of fibulin-5. We also detected substantial, but weak, interaction of fibulin-5 with LOX and LOXL3 in in vitro binding assays (unpublished data). However, we could not determine the specificity of these interactions because all of the fibulin-5 deletion mutants tested seemed to weakly interact with LOX or LOXL3. Intriguingly, the fibulin-5-LOXL1 interaction was markedly diminished by N-terminal deletion of fi bulin-5 (Fig. 7 B, top left, lanes 2 and 3) . Thus, fibulin-5 does not interact with LOXL1 after cleavage of fibulin-5, and this defect might contribute to the loss of elastogenic activity. Figure 6 . Fibulin-5 loses its elastogenic activity upon proteolytic cleavage. (A-E) Human skin fi broblasts were cultured in serum-free media without addition of proteins (A), with wild-type fi bulin-5 (B), with the cleaved form of fi bulin-5 (C), or with wild-type fi bulin-5 and 500 μM BAPN (D). Each FLAG-tagged recombinant protein was added to the culture at a fi nal concentration of 4 μg/ml. Cultures were stained with anti-FLAG antibody (top) and anti-human elastin antibody (middle). The bottom images were produced by superimposition of the top and middle images, together with DAPI nuclear staining. Bars, 50 μm. (E) Quantitation of insoluble (i.e., cross-linked and mature) elastin produced by cells cultured with various amounts of wild-type and cleaved fi bulin-5 added to the medium. Cultured skin fi broblasts were metabolically labeled with [ 3 H]valine during the culture period, and the radioactivity of the NaOH-insoluble fractions was quantitated. The radioactivity count was corrected by the relative cell number of separate wells measured with a modifi ed MTT assay, although neither wild-type nor cleaved fi bulin-5 signifi cantly affected the cell number (not depicted). Data were obtained as quadruplicates, and the mean ± the SD is shown.
Discussion
We have identified an elastic fiber-organizing activity of fi bulin-5/DANCE protein that is abrogated by proteolytic cleavage of the N-terminal domain in cell culture and in vivo. Our proposed molecular mechanism of elastic fi ber organization by fi bulin-5/DANCE protein is illustrated in Fig. 8 A. We call this the "Line DANCE model." According to this model, fulllength fi bulin-5 protein associates with microfi brils. Direct interaction of fi bulin-5 and fi brillin-1 (Freeman et al., 2005) may be important for this association. As fi bulin-5 serves as an integrin ligand through its N-terminal domain (Nakamura et al., 1999 (Nakamura et al., , 2002 , integrin-fi bulin-5 interaction, in addition to integrin-fi brillin interaction, may help the assembly to occur in the proximity of the cell surface. After fi bulin-5 interacts with microfi brils, tropoelastins accumulate on fi bulin-5 proteins and coacervate. LOXL enzymes tethered on the C-terminal domain of fi bulin-5 promote cross-linking of the aggregated tropoelastins, to form mature elastic fibers. In contrast, as illustrated in Fig. 8 B, the truncated form of fi bulin-5 cannot associate with microfi brils or integrins, and therefore is unable to promote the organization of the elastic fi ber assembly, although the truncated form of fi bulin-5 itself has the ability to bind tropoelastin and enhance coacervation of tropoelastin as well (unpublished data).
In this study, we fi rst succeeded in inducing the development of elastic fi bers in serum-free skin fi broblast culture by adding purifi ed fi bulin-5 protein. Tropoelastin and other elastic fi ber components were not organized into elastic fi bers without addition of fi bulin-5 protein, suggesting that fi bulin-5 is not only a necessary component of elastic fi bers (Nakamura et al., 2002; Yanagisawa et al., 2002) but also an organizer that can induce elastic fi ber assembly. Skin fi broblasts are known to develop abundant elastic fi bers in serum-containing media. However, serum contains various known and unknown factors, such as cytokines and growth factors, and also causes increases of total cell number and cell density, making it diffi cult to identify specifi c molecules that are important for elastogenesis. Indeed, we detected a signifi cant amount of fi bulin-5 in serum using immunoprecipitation and ELISA (unpublished data), which might contribute to the elastogenic activity of the serum to some extent. We detected abundant deposition of fi bulin-5 that may be derived from fi broblasts or from serum in serum-containing culture of skin fi broblasts, whereas endogenous fi bulin-5 was scarcely detected in serum-free culture (Fig. S1 ). This indicates that the dose of fi bulin-5 is crucial for elastic fi ber organization in this serum-free cell culture, and that the endogenous expression of fi bulin-5 alone is insuffi cient. Our serum-free elastogenesis system, in combination with gene knockdown by RNAi, would (A) Domain structures of the full-length fi bulin-5 and the fi bulin-5 deletion mutants used for in vitro binding assays. ∆N1-fi bulin-5 corresponds to the naturally cleaved form of fi bulin-5. These mutants were expressed as C-terminal-FLAG-tagged proteins. (B) Fibulin-5 binds to LOXL1, 2, and 4 through the C-terminal domain. 293T cells were transiently transfected with the vectors shown in A or a mock vector. Expression vectors for Myc-tagged LOX or LOXLs were also independently transfected into 293T cells. The conditioned media were harvested, and mixed. Each mixture was subjected to immunoprecipitation with anti-FLAG antibody, separated by SDS-PAGE, and analyzed by Western blotting with a monoclonal anti-Myc antibody.
be a useful tool to identify other factors that regulate elastic fi ber assembly, as unknown factors in the serum need not be taken into account.
It has been reported that fi bulin-5 can strongly interact with tropoelastin (Yanagisawa et al., 2002) . We found that fi bulin-5 not only binds with tropoelastin, but also promotes coacervation of tropoelastins, and thus plays a more positive role in the alignment and deposition of tropoelastin. Fibrillin-1 has also recently been reported to promote coacervation (Clarke et al., 2005) . Because fi bulin-5 interacts with both fi brillin-1 and tropoelastins (Yanagisawa et al., 2002; Freeman et al., 2005) , a fi bulin-5-fi brillin-1 complex might cooperatively promote coacervation. Coacervated tropoelastin molecules need to be cross-linked by LOX family enzymes for the development of mature elastic fi bers. Our data show that fi bulin-5 also promotes cross-linking of tropoelastin, which may be mediated by recruiting LOXL1, 2, and 4 in the vicinity of coacervated tropoelastin (Fig. 7 B) .
We found that a much higher level of the truncated form of fi bulin-5 was present in aged mouse skin than in young mouse skin (Fig. 4 B) . There are several possible interpretations of this result: (a) fi bulin-5 might be cleaved because of more protease activity in aged tissues; (b) truncated fi bulin-5 might be stable and accumulate during life; or (c) truncated fi bulin-5 might be more easily extracted from aged elastic fi bers than from young elastic fi bers. In any case, the truncated form of fi bulin-5 cannot contribute to new elasto genesis, and therefore the decrease in full-length fi bulin-5 may directly refl ect a decrease in the elastogenic activity of aged tissues.
In this study, we could not exclude the possibility that the truncated form of fi bulin-5 might play some roles in elastogenesis in vivo. Although truncated fi bulin-5 cannot contribute to new elastogenesis as it cannot interact with microfi brils, fi bulin-5 protein cleaved after deposition onto microfi brils might take part in subsequent processes of elastogenesis, as binding with tropoelastin and facilitating coacervation of tropoelastin are not compromised by the N-terminal domain cleavage (unpublished data).
To clarify the physiological consequences of the cleavage of fi bulin-5, further studies will be needed using gene-targeted mice in which a cleavage-resistant mutant form of fi bulin-5 is knocked-in.
So far, elastic matrices have been considered to be designed to maintain elastic function for a lifetime (Kielty et al., 2002) . Elastin is reported to have an exceptionally long half-life, and to have a turnover rate which approaches our lifespan (Shapiro et al., 1991) . On the other hand, elastase activity is provoked by exposure to sunlight and by smoking, causing degradation of the elastic fi bers of the skin and lung, respectively (Fisher et al., 1996; Hautamaki et al., 1997) . This implies that elastogenic activity needs to be maintained even in the adult tissues to regenerate elastic fi bers. Indeed, we detected a signifi cant amount of fi bulin-5 in the serum of aged mice (unpublished data), and we and others reported that the expression of fi bulin-5 is up-regulated in some pathological conditions, such as in atherosclerotic lesions (Kowal et al., 1999; Nakamura et al., 1999; Nguyen et al., 2004) , lung injury by elastase (Kuang et al., 2003) , and pulmonary hypertension (Merklinger et al., 2005) . The potent elastogenic activity of fi bulin-5 might provide future therapeutic applications for aging-associated diseases, such as emphysema and arteriosclerosis, or cosmetic applications for wrinkled skin. Application of fi bulin-5 might be extended to tissue engineering, to make elastic skin or vessels by using cell cultures. Further studies are needed to examine whether fibulin-5 might improve age-related changes of elastic matrices in vivo.
In summary, we demonstrated the elastic fi ber organizing activity of fi bulin-5 that is abrogated by age-associated proteolytic cleavage. We demonstrated that the addition of recombinant fi bulin-5 protein induces elastic fi ber development, and that a decrease in full-length fi bulin-5 caused by proteolytic cleavage may contribute to the loss of the elastogenic potential in aged elastic tissues. Our fi ndings might provide a molecular pathway to future therapeutic applications of the elastic fi ber organizing activity of fi bulin-5. 
Materials and methods
Cell culture 293T cells and human skin fi broblasts (HSFs) were maintained in DME (Sigma-Aldrich) supplemented with 2 mM glutamine, 10% penicillin/ streptomycin, and 10% FBS at 37°C in 5% CO 2 . HSFs were provided by M. Naito (Kyoto University, Kyoto, Japan).
Plasmid construction
Human full-length fi bulin-5 cDNA was cloned as previously described (Nakamura et al., 1999) . pEF6/V5 (Invitrogen) was modifi ed by incorporation of a C-terminal FLAG-tag or Myc-tag (pEF6/FLAG, pEF6/Myc). The fi bulin-5 ∆N1-(∆nt 247-399), ∆N2-(∆nt 247-504), ∆M-(∆nt 505-1,110), and ∆C-(∆nt 1, 114-1,512) fi bulin-5 cDNAs were subcloned into pEF6/FLAG. Human fi bulin-5 cDNA sequences are numbered according to GenBank accession no. AF112152. Human full-length LOXL1, 2, 3, and 4 cDNAs were obtained from IMAGE (available from GenBank under accession no. BC015090, BC000594, BC071865, and BC013153, respectively), and subcloned into pEF6/Myc. All constructs were confi rmed by sequencing (ABI Prism 3100).
Protein purifi cation pEF6/V5 (Invitrogen) was modifi ed by incorporation of a C-terminal histidine and FLAG-tag. Human wild-type and each mutant fi bulin-5 cDNA were subcloned into pEF6/FLAG-His. The respective stable blasticidin-resistant 293T cell clones were then obtained by transfection with these expression vectors. Recombinant proteins were purifi ed from the serum-free conditioned medium of stable lines using Ni-NTA metal affi nity resin (QIAGEN), and desalted with a Hi-Trap desalting column (GE Healthcare). Protein concentrations were determined with Coomassie Plus-200 Protein Assay Reagent (Pierce Chemical Co.). Human tropoelastin cDNA was cloned from human skin fi broblasts by RT-PCR. Of the four splice variants obtained, the longest cDNA, which codes one of the splicing variants of the elastin gene (ELNc; available from GenBank under accession no. BC035570), was subcloned into pTrcHis vector (Invitrogen) and expressed in bacteria, followed by protein purifi cation with Ni-NTA column (GE Healthcare), as previously described (Wachi et al., 2005) .
In vitro elastogenesis assay and immunofl uorescence
HSFs were subconfl uently plated on microscope cover glasses (Fisher Scientifi c) . 3 d after plating, culture media were changed to serum-free DME/F12 (Sigma-Aldrich), and purifi ed recombinant fi bulin-5 proteins were added, and the incubation was continued for another 10 d. The cells were fi xed with 100% methanol, and blocked with 2% BSA. The primary antibodies used were anti-FLAG M2 monoclonal (1/100; Sigma-Aldrich), anti-human elastin polyclonal (1/100; EPC, PR533), anti-human fi bulin-5 monoclonal (1/100; 10A), and anti-human fi brillin-1 polyclonal (1/100; EPC, PR217) antibodies. The secondary antibodies used were Alexa Fluor 488, 546, or 647 anti-rabbit or -mouse IgG (1/100; Invitrogen). After staining with DAPI, stained cells were mounted with a Prolong Gold Antifade Kit (Invitrogen). Fluorescence images were sequentially collected using a confocal microscope featuring 405-, 488-, 543-, and 633-nm laser lines with an open pinhole setting operated by the built-in software; either a microscope (LSM510 META; Carl Zeiss MicroImaging, Inc.) with a C-Apo 40×/1.2 NA lens (Figs. 1 and 6 ) or a microscope (FV-1000; Olympus) with a UPlanSApo 40×/0.9 NA lens (Figs. 5 and S1). Image fi les were converted to TIFF format using the operating software, merged, linearly contrast stretched (with the same setting in each set of experiments) using Photoshop CS2 (Adobe), and imported into Illustrator CS2 (Adobe) for assembly. Anti-human fi bulin-5 monoclonal antibody (10A) was raised by Iwaki Co., Ltd. by immunization of fi bulin-5-defi cient mice with purifi ed recombinant human fi bulin-5 protein.
Coacervation assay
Coacervation of tropoelastin with or without fi bulin-5 protein was assessed using the method described (Clarke et al., 2005) . Soluble tropoelastin and fi bulin-5 were prepared in PBS and mixed on ice. Each reaction mixture was transferred to an 8-channel quartz cuvette for light scattering measurements at 440 nm. The temperature of a spectrophotometer (UV-1650; Shimazu) fi tted with a heating/cooling block was regulated by a circulating water bath. All channels were simultaneously cooled and heated in the heating/cooling block by the circulating water.
Transfection, in vitro binding assay, and Western blotting 293T cells were transfected using Lipofectamine PLUS (Invitrogen). The mixtures of conditioned media were subjected to immunoprecipitation with anti-FLAG M2 affi nity gel (Sigma-Aldrich). After washing, immune complexes were resolved by SDS-PAGE, transferred to PVDF mem branes (Bio-Rad Laboratories), and reacted with HRP-conjugated anti-Myc monoclonal (9E10; 1/500; Santa Cruz Biotechnology) or anti-FLAG M2 monoclonal (1/1,000; Sigma-Aldrich) antibody. Signals were detected using Western Lightning Chemiluminescence Reagent PLUS (Perkin Elmer).
Tissue extraction and Western blotting
Proteins were extensively extracted from skin tissues with 8 M urea solution. After dialysis against PBS, the protein concentration was measured with Coomassie Plus-200 Protein Assay Reagent. Protein samples of the same amount were subjected to SDS-PAGE (Invitrogen), followed by Western blotting with anti-fi bulin-5 antibody (1/400, BSYN2473). HRP-conjugated anti-rabbit antibody (1/2,000; Santa Cruz Biotechnology) was used as a secondary antibody.
Transmission electron microscopy
For transmission electron microscopy, skin tissues were fi xed with 4% paraformaldehyde, 2.5% glutaraldehyde, 0.1% tannic acid in 0.1 M caco dylate buffer. Sections were then stained with uranyl acetate.
Quantitative measurement of insoluble elastin
HSFs were subconfl uently plated on 60-mm dishes in quadruplicates. 3 d after plating, 20 μCi [ 3 H]valine was added to each dish, together with purifi ed recombinant fi bulin-5 protein or cleaved fi bulin-5 protein. The cultures were then incubated at 37°C in 5% CO 2 for 10 d. The cells were harvested in 0.1 M acetic acid on ice. After centrifugation, the pellets were boiled in 0.1 N NaOH for 1 h. Subsequently, the NaOH-insoluble pellets were boiled with 5.7 N HCl for 1 h, mixed with scintillation fl uid, and measured for radioactivity with a scintillation counter (Beckman Coulter).
Reverse transcription-polymerase chain reaction and quantitative PCR Total RNAs were extracted using RNeasy Plus Mini Kit (QIAGEN) and transcribed to cDNA with random hexamers using the SuperScript III FirstStrand Synthesis System (Invitrogen). For quantitative PCR, the reaction was performed with a QuantiTect SYBR Green PCR kit (QIAGEN), and the products were analyzed with the Mx3000P QPCR System (Stratagene). Primers used for quantitative PCR are provided in Table S1 (available at http://www.jcb.org/cgi/content/full/jcb.200611026/DC1). Fig. S1 shows that serum induces fi bulin-5 deposition on microfi brils. Table S1 shows primers used for quantitative PCR. The online version of this article is available at http://www.jcb.org/cgi/content/full/jcb.200611026/DC1.
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